4.6 Article

Immunogenetics of the response to HBsAg vaccination

Journal

AUTOIMMUNITY REVIEWS
Volume 2, Issue 5, Pages 248-257

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1568-9972(03)00031-4

Keywords

hepatitis B surface antigen; immunogenetics; major histocompatibility complex; vaccine

Categories

Funding

  1. NIAID NIH HHS [5R01 AI49730, 5R01 AI20720] Funding Source: Medline

Ask authors/readers for more resources

The major envelope protein of the hepatitis B virus (HBV), the HBsAg, constitutes the current preventative vaccine, which represents the first subunit viral vaccine developed. The genetics of the immune response to HBsAg has been extensively studied both in humans and mice. Murine studies begun over 20 years ago indicated that at least two MHC class II and one MHC class III genes regulate anti-HBs immune responses. Additional MHC-linked genes influence the immune responses to the higher molecular weight (pre-S) components of the HBV envelope. The murine studies predicted even more complex MHC gene regulation of human immune responses to the HBsAg and that complexity certainly has been demonstrated during the ensuing years. This brief review is an attempt to summarize our current understanding of the MHC genes that influence the immune response to the HBsAg and possible mechanisms of action. (C) 2003 Elsevier Science B.V All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available